Morgan Stanley Downgrades Emerson (EMR) to Equalweight
Tweet
Share
E-mailGet Alerts EMR Hot Sheet
Price: $162.04 -0.69%
Rating Summary:
26 Buy, 20 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 22 | New: 20
Rating Summary:
26 Buy, 20 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 22 | New: 20
Join SI Premium – FREE
Morgan Stanley downgraded Emerson (NYSE: EMR) from Overweight to Equalweight.
For an analyst ratings summary and ratings history on Emerson click here. For more ratings news on Emerson click here.
Shares of Emerson closed at $54.70 yesterday.
For an analyst ratings summary and ratings history on Emerson click here. For more ratings news on Emerson click here.
Shares of Emerson closed at $54.70 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- William Blair Downgrades Enovix Corporation (ENVX) to Market Perform
- Oppenheimer Downgrades AtaiBeckley Inc (ATAI) to Perform
- BWS Financial Downgrades Inter Parfums (IPAR) to Sell
Create E-mail Alert Related Categories
DowngradesRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
